BR100 Increased By (0.01%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.38 Increased By ▲ 0.06 (0.95%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 62.55 Increased By ▲ 0.10 (0.16%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.73 Increased By ▲ 0.14 (1.21%)
CSIL 5.91 Increased By ▲ 0.19 (3.32%)
FCCL 61.71 Increased By ▲ 0.17 (0.28%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.69 Increased By ▲ 0.01 (0.04%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.32 Decreased By ▼ -1.96 (-1.12%)
NCPL 51.83 Decreased By ▼ -0.94 (-1.78%)
NPL 54.03 Decreased By ▼ -0.09 (-0.17%)
OGDC 315.87 Increased By ▲ 2.48 (0.79%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 226.07 Increased By ▲ 4.26 (1.92%)
PRL 80.28 Increased By ▲ 1.20 (1.52%)
PTC 46.64 Decreased By ▼ -0.21 (-0.45%)
SSGC 23.82 Decreased By ▼ -0.05 (-0.21%)
TBL 9.24 Decreased By ▼ -0.07 (-0.75%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.54 Decreased By ▼ -0.57 (-2.27%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 25.98 Decreased By ▼ -0.27 (-1.03%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)

KARACHI: The School of Business Studies (SBS), IBA Karachi, signed an agreement with The Searle Company, at the IBA Main Campus, to establish the Rashid Abdulla Consumer Neuroscience Lab. The ceremony was attended by The Searle Company's Group MD & CEO, Dr S Nadeem Ahmed, while IBA was represented by the Executive Director, IBA, Dr S Akbar Zaidi.

The Rashid Abdulla Consumer Neuroscience Lab will transform consumer research and collection of data through knowledge and understanding of neuro-marketing and behavioural research. This is a huge opportunity for academics and practitioners to get unbiased responses in real time to enable an accurate depiction of buying behaviour.

IBA is Pakistan's premier institution of higher learning, teaching and academic excellence. This establishment set forth on its journey of excellence in 1955 under the guidance of reputed scholars from the Wharton School of Finance, University of Pennsylvania, and the University of Southern California.

Today, Searle is one of the leading pharmaceutical companies in Pakistan, with a strength of 3,000+ employees; nine state-of-the-art cGMP compliant and purpose-built manufacturing facilities in Lahore, Karachi, and Liège - Belgium.

These facilities are equipped to manufacture almost all pharmaceutical dosage forms from Nutraceuticals to Biosimilars. Searle supplies products in Pakistan and many other countries in South Asia, South East Asia, Africa, GCC /Gulf region, and other Francophone countries.

Copyright Business Recorder, 2021

Comments

Comments are closed for this article.